Literature DB >> 19480999

Parvovirus B19: its role in chronic arthritis.

Ines Colmegna1, Noah Alberts-Grill.   

Abstract

B19 infection-associated joint symptoms occur most frequently in adults, usually presenting as a self-limited, acute symmetric polyarthritis affecting the small joints of the hands, wrists, and knees. A small percentage of patients persist with chronic polyarthritis that mimics rheumatoid arthritis raising the question of whether B19 virus may have a role as a concomitant or precipitating factor in the pathogenesis of autoimmune conditions. Comprehensive and updated reviews address different aspects of human parvovirus infection. This article focuses on the evidence supporting the arthritogenic potential of the B19 virus and the proposed mechanisms that underlie it.

Entities:  

Mesh:

Year:  2009        PMID: 19480999     DOI: 10.1016/j.rdc.2009.03.004

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  11 in total

1.  Epidemiological and clinical characteristics of human parvovirus B19 infections during 2006-2009 in Northern Greece.

Authors:  M Exindari; D Chatzidimitriou; A Melidou; G Gioula; L Ziogou; E Diza
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

2.  Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.

Authors:  J Michael Soucie; Christine De Staercke; Paul E Monahan; Michael Recht; Meera B Chitlur; Ralph Gruppo; W Craig Hooper; Craig Kessler; Roshni Kulkarni; Marilyn J Manco-Johnson; Jerry Powell; Meredith Pyle; Brenda Riske; Hernan Sabio; Sean Trimble
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

3.  Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?

Authors:  Eric Delwart
Journal:  Transfusion       Date:  2012-07       Impact factor: 3.157

4.  DNA Binding and Cleavage by the Human Parvovirus B19 NS1 Nuclease Domain.

Authors:  Jonathan L Sanchez; Zachary Romero; Angelica Quinones; Kristiane R Torgeson; Nancy C Horton
Journal:  Biochemistry       Date:  2016-11-17       Impact factor: 3.162

5.  High-Resolution Structure of the Nuclease Domain of the Human Parvovirus B19 Main Replication Protein NS1.

Authors:  Jonathan L Sanchez; Niloofar Ghadirian; Nancy C Horton
Journal:  J Virol       Date:  2022-04-18       Impact factor: 6.549

Review 6.  Arthritis susceptibility and the gut microbiome.

Authors:  Veena Taneja
Journal:  FEBS Lett       Date:  2014-05-27       Impact factor: 4.124

Review 7.  Human bocavirus: Current knowledge and future challenges.

Authors:  Marcello Guido; Maria Rosaria Tumolo; Tiziano Verri; Alessandro Romano; Francesca Serio; Mattia De Giorgi; Antonella De Donno; Francesco Bagordo; Antonella Zizza
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

8.  Development & standardization of an in-house IgM indirect ELISA for the detection of parvovirus B19 infections.

Authors:  Kumaran Vadivel; Mageshbabu Ramamurthy; Sathish Sankar; Amita Jain; Padma Srikanth; Asit Ranjan Ghosh; Balaji Nandagopal; Aravindan Nair; Gopalan Sridharan
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

9.  Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients.

Authors:  Nguyen L Toan; Bui T Sy; Le H Song; Hoang V Luong; Nguyen T Binh; Vu Q Binh; Reinhard Kandolf; Thirumalaisamy P Velavan; Peter G Kremsner; C-Thomas Bock
Journal:  BMC Infect Dis       Date:  2013-08-15       Impact factor: 3.090

10.  No Definite Association between Human Parvovirus B19 Infection and Behçet Disease.

Authors:  Mojtaba Habibagahi; Zahra Habibagahi; Said-Mostafa Saidmardani; Faezeh Sadeghian
Journal:  Iran J Med Sci       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.